Beximco Pharmaceuticals Ltd. GDR Stock
The Beximco Pharmaceuticals Ltd. GDR price is unchanged compared to yesterday.
Pros and Cons of Beximco Pharmaceuticals Ltd. GDR in the next few years
Pros
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Beximco Pharmaceuticals Ltd. GDR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Beximco Pharmaceuticals Ltd. GDR | 0.000% | 0.000% | 10.043% | 18.119% | 14.955% | 16.516% | -46.907% |
| Eledon Pharmaceuticals Inc. | 14.570% | 27.374% | 27.374% | -40.625% | 78.125% | 7.547% | -81.905% |
| SELLAS Life Sciences Group Inc | 4.310% | 13.368% | 28.529% | 278.059% | 52.557% | 196.639% | -44.466% |
| Grifols S.A. ADR | -2.000% | -5.769% | -3.289% | -6.962% | -3.289% | -7.547% | -45.668% |
News
Why Atai Life Sciences Stock Was So Lively This Week
Atai Life Sciences (NASDAQ: ATAI), a biotech focused on developing psychedelic-based medicines to treat mental health disorders, was a standout stock over the past few days in its rather limited
Why Atai Life Sciences Stock Crushed It on Tuesday
Atai Life Sciences (NASDAQ: ATAI), an ambitious biotech that targets mental health disorders, was a hot item among equity investors Tuesday. The company saw its share price rise by just under 15%